FASLG and glaucoma: As a complex multifactorial disease, we predict the most successful neuroprotective therapy for glaucoma will have to impact multiple pathways and the data presented herein strongly support pursuing the FasL-Fas signaling pathway as an optimal target for successful neuroprotection in glaucoma.